EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2 / GBA mutated Parkinson's disease

Fabin Lin iD, Xinlin Ruan, Xinyang Zou, Huidan Weng, Yuqi Zeng, Jiayi Zheng, Qinyong Ye, Fangang Meng iD, Xiaochun Chen, Guoen Cai iD

CNS Neuroscience & Therapeutics · 2024-06 · 30 (6)

DOI: 10.1111/cns.14728 ↗

Kurz gefasst

Fachartikel in der Zeitschrift CNS Neuroscience & Therapeutics, online erschienen am 04.06.2024. Verfasst von Fabin Lin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Center for Cognitive Neurology, Institute of Clinical Neurology, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Leucine-Rich Repeat Serine-Threonine Protein Kinase-2, Parkinson Disease, Prodromal Symptoms, Biomarkers. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Province Joint Funds for the Innovation of Science and Technology, Clinical Key Specialty of Fujian Province (Neurology).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Prodromal Parkinson's disease (PD) carriers of dual leucine‐rich repeat kinase 2 (LRRK2) and glucosylceramidase β (GBA) variants are rare, and their biomarkers are less well developed.

Objective

This study aimed to investigate the biomarkers for diagnosing the prodromal phase of LRRK2‐GBA‐PD (LRRK2‐GBA‐prodromal).

Methods

We assessed the clinical and whole‐brain white matter microstructural characteristics of 54 prodromal PD carriers of dual LRRK2 (100% M239T) and GBA (95% N409S) variants, along with 76 healthy controls (HCs) from the Parkinson's Progression Markers Initiative (PPMI) cohort.

Results

By analyzing the four values of 100 nodes on 20 fiber bundles, totaling 8000 data points, we identified the smallest p value in the fractional anisotropy (FA) value of the 38th segment of left corticospinal tract (L‐CST) with differences between LRRK2‐GBA‐prodromal and HCs ( p = 8.94 × 10 −9 ). The FA value of the 38th node of the L‐CST was significantly lower in LRRK2‐GBA‐prodromal (FA value, 0.65) compared with HCs (FA value, 0.71). The receiver‐operating characteristic curve showed a cut‐off value of 0.218 for the FA value of L‐CST, providing sufficient sensitivity (79.2%) and specificity (72.2%) to distinguish double mutation prodromal PD from the healthy population.

Conclusion

L‐CST, especially the 38th node, may potentially serve as a biomarker for distinguishing individuals with double mutation prodromal PD from the healthy population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2Parkinson DiseaseProdromal SymptomsBiomarkersMutationPyramidal TractsGlucosylceramidaseHumansMaleFemaleMiddle AgedAgedDiffusion Tensor ImagingCohort StudiesFunctional Laterality

Stichwörter der Autor:innen

GBALRRK2diffusion tensor imagesprodromal Parkinson's diseasewhite matter

Substanzen

Leucine-Rich Repeat Serine-Threonine Protein Kinase-2LRRK2 protein, humanBiomarkersGlucosylceramidaseGBA protein, human

Autor:innen und Institutionen

  • Department of Neurology, Center for Cognitive Neurology, Institute of Clinical Neurology, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Institute of Geriatrics, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Key Laboratory of Molecular Neurology, Fujian Medical University, Fuzhou, China.
  • Department of Neurosurgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Beijing Neurosurgical Institute, Beijing Tiantan Hospital, Capital Medical University, Beijing, China.

ORCID-Profile: Fabin Lin, Fangang Meng, Guoen Cai

Förderung

  • Fujian Province Joint Funds for the Innovation of Science and Technology
  • Clinical Key Specialty of Fujian Province (Neurology)

Zitieren

APA

Lin, F., Ruan, X., Zou, X., Weng, H., Zeng, Y., Zheng, J., Ye, Q., Meng, F., Chen, X., & Cai, G. (2024). Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2 / GBA mutated Parkinson's disease. CNS Neuroscience & Therapeutics, 30(6). https://doi.org/10.1111/cns.14728

Vancouver

Lin F, Ruan X, Zou X, Weng H, Zeng Y, Zheng J, et al. Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2 / GBA mutated Parkinson's disease. CNS Neuroscience & Therapeutics. 2024;30(6). doi:10.1111/cns.14728

BibTeX
@article{Lin2024,
  author = {Lin, Fabin and Ruan, Xinlin and Zou, Xinyang and Weng, Huidan and Zeng, Yuqi and Zheng, Jiayi and Ye, Qinyong and Meng, Fangang and Chen, Xiaochun and Cai, Guoen},
  title = {Left corticospinal tract could be a biomarker to identify the dual prodromal LRRK2 / GBA mutated Parkinson's disease},
  journal = {CNS Neuroscience & Therapeutics},
  year = {2024},
  volume = {30},
  number = {6},
  doi = {10.1111/cns.14728}
}
Kostenlos starten →